Beam Therapeutics reported cash from operations of -$66.10M and free cash flow of -$68.51M for the quarter ended Jun 2026, up 13.5% year over year. This cash flow statement covers 30 quarters of results from Mar 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||||
| Net Income | -28.12M | -64.71M | -75.58M | -79.91M | -84.08M | -38.35M | -88.97M | -82.78M | -96.09M | 142.76M | -92.28M | -91.05M | -96.67M | -90.35M | -109.42M | -102.29M | -112.73M | 261.10M | -97.35M | -119.07M | ||||||||||
| Share-based Compensation | 12.97M | 15.50M | 18.04M | 21.58M | 22.21M | 22.50M | 23.92M | 26.28M | 25.84M | 22.62M | 29.28M | 31.60M | 29.56M | 30.22M | 26.68M | 95.70M | 84.20M | 20.45M | 19.04M | 90.90M | ||||||||||
| Gains from Investment Securities | 0.13M | -1.78M | 0.03M | 0.03M | 0.03M | 0.03M | -1.00M | 0.77M | -0.51M | 0.20M | ||||||||||||||||||||
| Cash from Operations | 3.01M | 1.83M | 218.49M | -52.28M | -74.50M | -69.19M | -109.81M | -84.67M | -89.78M | 135.07M | -99.75M | -83.01M | -88.12M | -76.36M | -103.88M | -76.45M | -81.48M | -83.29M | -128.51M | -66.10M | ||||||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||||||
| Amortizatization of Intangibles | 0.04M | 0.06M | ||||||||||||||||||||||||||||
| Depreciation & Amortization (CF)Depreciation & Amortization | 1.75M | 2.63M | 3.31M | 3.42M | 3.47M | 3.94M | 4.65M | 4.82M | 5.19M | 5.36M | 5.43M | 5.58M | 5.47M | 5.44M | 5.53M | 5.54M | 5.56M | 5.67M | 5.61M | 5.41M | ||||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||||
| Change in Account Payables | -1.72M | 2.16M | -1.25M | 0.10M | 0.62M | 2.90M | -0.23M | -2.53M | -3.04M | -1.77M | 1.28M | 1.77M | -0.70M | -0.55M | 3.79M | 2.64M | -1.59M | 1.19M | 2.22M | 1.21M | ||||||||||
| Change in Accured Expenses | 1.17M | 41.10M | -16.53M | 3.40M | 3.94M | 8.44M | -9.89M | -0.27M | 7.42M | 70.40M | -24.27M | -19.49M | -9.85M | -4.08M | -18.46M | 9.87M | 1.98M | 14.30M | -16.26M | 1.31M | ||||||||||
| Other Working Capital Changes | 3.32M | 0.82M | 9.19M | 3.16M | 1.15M | -1.07M | 8.40M | -1.93M | 3.57M | -20.21M | 5.53M | -11.77M | -3.44M | -3.27M | -3.30M | -3.33M | -3.38M | -3.50M | 31.86M | -38.88M | ||||||||||
| Investing Activities | ||||||||||||||||||||||||||||||
| Capital Expenditures | 5.78M | 13.37M | 15.31M | 13.60M | 11.79M | 8.26M | 10.68M | 11.52M | 7.95M | 3.59M | 2.44M | 1.96M | 1.58M | 2.97M | 3.06M | 3.14M | 5.01M | 3.73M | 2.23M | 2.41M | ||||||||||
| Acquisitions | ||||||||||||||||||||||||||||||
| Change in Acquisitions & Divestments | 260.39M | 106.35M | 160.31M | 350.57M | 333.64M | 360.09M | 298.00M | 365.52M | 271.43M | 154.96M | 144.22M | 223.93M | 183.00M | 129.25M | 217.15M | 166.67M | 240.64M | 218.03M | 181.29M | 173.00M | ||||||||||
| Cash from Investing Activities | 76.11M | -77.50M | -537.34M | -1.26M | -36.17M | 113.44M | 25.45M | -41.48M | -10.23M | 98.10M | -53.46M | 87.49M | 24.70M | 126.28M | -125.09M | -170.41M | 65.66M | 108.41M | 25.27M | -9.88M | ||||||||||
| Financing Activities | ||||||||||||||||||||||||||||||
| Other financing activities | 2.70M | 1.97M | 1.41M | 0.05M | 1.61M | -0.00M | 3.39M | 0.70M | 1.29M | 28.21M | 1.68M | 0.24M | 0.71M | 2.98M | 1.50M | 0.97M | 0.41M | 1.89M | 2.02M | 7.52M | ||||||||||
| Debt Issuance and Repayment | ||||||||||||||||||||||||||||||
| Long-Term Debt Issuances | 93.89M | |||||||||||||||||||||||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||||||
| Net Shares Issued and Repurchased | 1.79M | 1.43M | 2.22M | 1.77M | 2.36M | 1.95M | 2.68M | 2.16M | 2.72M | 1.79M | ||||||||||||||||||||
| Net Equity Issued and Repurchased | 318.92M | 20.24M | 54.00M | 22.36M | 31.89M | 93.98M | 107.64M | 34.95M | ||||||||||||||||||||||
| Misc. | ||||||||||||||||||||||||||||||
| Cash from Financing Activities | 320.89M | 21.54M | 55.68M | 22.34M | 1.56M | 32.01M | 98.42M | 107.54M | 36.78M | 33.71M | 2.90M | 0.13M | 1.26M | 3.44M | 473.38M | 1.11M | 1.68M | 1.89M | 96.61M | 7.52M | ||||||||||
| Change in Cash | 400.01M | -54.12M | -263.17M | -31.20M | -109.11M | 76.26M | 14.05M | -18.61M | -63.24M | 266.88M | -150.31M | 4.62M | -62.16M | 53.36M | 244.41M | -245.75M | -14.15M | 27.00M | -6.64M | -68.45M | ||||||||||
| Free Cash Flow | -2.77M | -11.54M | 203.18M | -65.87M | -86.28M | -77.45M | -120.49M | -96.19M | -97.73M | 131.48M | -102.19M | -84.97M | -89.70M | -79.33M | -106.95M | -79.59M | -86.49M | -87.02M | -130.75M | -68.51M | ||||||||||
| Net Cash Flow | 400.01M | -54.12M | -263.17M | -31.20M | -109.11M | 76.26M | 14.05M | -18.61M | -63.24M | 266.88M | -150.31M | 4.62M | -62.16M | 53.36M | 244.41M | -245.75M | -14.15M | 27.00M | -6.64M | -68.45M |